Back
PTC Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
PTCT
PTC Therapeutics
Last Price:
$48.56
Seasonality Move:
9.1%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.
PTC Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.54 | Sell |
20-day SMA: | 49.01 | Sell |
50-day SMA: | 48.25 | Buy |
200-day SMA: | 46.53 | Buy |
8-day EMA: | 42 | Buy |
20-day EMA: | 26.74 | Buy |
50-day EMA: | 13.29 | Buy |
200-day EMA: | 3.73 | Buy |
PTC Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 13.45 | Buy |
Relative Strength Index (14 RSI): | 47.85 | Sell |
Chaikin Money Flow: | -301918 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.33 - 50.55) | Sell |
Bollinger Bands (100): | (45.24 - 53.2) | Sell |
PTC Therapeutics Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for PTC Therapeutics Stock
Is PTC Therapeutics Stock a Buy?
-
PTC Therapeutics share price is 48.53 while PTCT 8-day simple moving average is 48.54, which is a Sell signal.
-
The stock price of PTCT is 48.53 while PTC Therapeutics 20-day SMA is 49.01, which makes it a Sell.
-
PTC Therapeutics 50-day simple moving average is 48.25 while PTCT share price is 48.53, making it a Buy technically.
-
PTCT stock price is 48.53 and PTC Therapeutics 200-day simple moving average is 46.53, creating a Buy signal.
PTCT Technical Analysis vs Fundamental Analysis
Sell
32
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy or a Sell?
-
PTC Therapeutics stock is rated a SellThe current PTC Therapeutics [PTCT] share price is $48.53. The Score for PTCT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
PTC Therapeutics Stock Info
Market Cap:
3.8B
Price in USD:
48.53
Share Volume:
552.7K
PTC Therapeutics 52-Week Range
52-Week High:
58.38
52-Week Low:
29.02
Sell
32
PTC Therapeutics (PTCT)
is a Sell
PTC Therapeutics Share Price Forecast
-
What is the PTC Therapeutics stock price today?The PTC Therapeutics stock price is 48.53 USD today.
-
Will PTCT stock go up or go down?PTC Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is PTC Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, PTC Therapeutics is overvalued.
Is PTC Therapeutics Stock a Buy?
-
PTC Therapeutics share price is 48.53 while PTCT 8-day exponential moving average is 42.00, which is a Buy signal.
-
The stock price of PTCT is 48.53 while PTC Therapeutics 20-day EMA is 26.74, which makes it a Buy.
-
PTC Therapeutics 50-day exponential moving average is 13.29 while PTCT share price is 48.53, making it a Buy technically.
-
PTCT stock price is 48.53 and PTC Therapeutics 200-day simple moving average is 3.73, creating a Buy signal.
Fundamental Analysis of PTC Therapeutics
Is PTC Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.93 per share, a decrease next quarter of $0.10 per share, an increase this year of $11.53 per share, and a decrease next year of $9.47 per share.
Technical Analysis of PTC Therapeutics
Should I short PTC Therapeutics stock?
-
PTCT Moving Average Covergence Divergence (MACD) indicator is 13.45, suggesting PTC Therapeutics is a Buy
-
PTC Therapeutics Relative Strength Index (RSI) is 47.85, which suggest PTC Therapeutics is oversold
-
The Bollinger Bands (25) for PTC Therapeutics is (48.33 - 50.55), which suggest PTC Therapeutics is a Sell
-
The Bollinger Bands (100) for PTC Therapeutics is (45.24 - 53.2), which suggest PTC Therapeutics is a Sell
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.